A feasibility study of carboplatin with fixed dose of gemcitabine in ‘unfit’ patients with advanced bladder cancer

This publication has 18 references indexed in Scilit:

• Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
  Journal of Clinical Oncology, 2000
• Carboplatin-Gemcitabine Treatment of Patients with Transitional Cell Carcinoma of the Bladder and Impaired Renal Function
  Oncology, 2000
• Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial
  Annals of Oncology, 1999
• Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy
  Journal of Clinical Oncology, 1999
• Gemcitabine Plus Cisplatin, an Active Regimen in Advanced Urothelial Cancer: A Phase II Trial of the National Cancer Institute of Canada Clinical Trials Group
  Journal of Clinical Oncology, 1999
• A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum
  European Journal of Cancer, 1998
• Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.
  Journal of Clinical Oncology, 1997
• Carboplatin-based chemotherapy for bladder cancer
  Cancer Treatment Reviews, 1993
• Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Carboplatin, Methotrexate and Vinblastin (Carbo-MV) for Advanced Urothelial Cancer A Phase II Trial
  American Journal of Clinical Oncology, 1991